D-0873-2016 Class I Terminated
FDA drug recall D-0873-2016 was initiated by Sanofi-Aventis U.S. LLC on Oct 28, 2015 and is designated Class I. Reason for recall: Defective Delivery System; potential to have inaccurate dosage delivery The recall status is terminated (terminated Jul 15, 2025). Affected quantity: 159,000 prefilled injectors.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 1, 2016
- Initiation Date
- Oct 28, 2015
- Termination Date
- Jul 15, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 159,000 prefilled injectors
Product description
Auvi-Q (epinephrine injection, USP) Auto-Injector, 0.15 mg (a) 2 prefilled auto injectors + 1 trainer (NDC 0024-5831-02) and (b) 1 prefilled auto injector + 1 trainer (NDC 0024-5831-00), Rx Only, Manufactured for Sanofi-Aventis US, LLC Bridgewater, NJ 08807 A Sanofi Company
Reason for recall
Defective Delivery System; potential to have inaccurate dosage delivery
Distribution pattern
Nationwide
Code information
a) 2144144, exp 10/2015; 2469674, exp 04/2016; 2506492, 2546978, 2546979, exp 05/2016; 2654817, 2654818, exp 06/2016; 2692143, 2692144, exp 07/2016; 2719838, exp 08/2016; 2824845, 2891021, 2857530, exp 09/2016; 2883631, 2883632, exp 10/2016; 2883633, 2945429, 3028243, exp 11/2016; 3037230, 2966680, 2974276, 2974280, exp 12/2016; and b) 2525474, exp 05/2016
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0873-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026